Thursday 27 May 2021

BioLargo (BLGO) Discusses Elimination of Convertible Debt and Progress on Commercialization of PFAS Treatment Technology with The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - May 27, 2021) - The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO), a company that invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. President and CEO of BioLargo, Dennis P. Calvert, joined Stock Day host Everett Jolly for an interview.

Jolly began the interview by commenting on the company's latest announcements, including a recent press release detailing the elimination of almost all of the company's convertible debt. "We took quite a bit of risk [three years ago]; we needed that capital and we have put it to great work. We have advanced two platform technologies that are now at a commercial-ready stage, they're dramatic and they have a big future," said Calvert. "The opportunities that are coming to us are so big and so expansive, and it's really a tribute to our great technology and to our people."

"We really needed to get that convertible debt out of the way," continued Calvert, noting that the company's debt peaked at $7.6 million in 2018. "Since then, we have retired all [but $50,000] of this convertible debt, which has been continuing to put pressure on the stock. So, it's a great moment."

Jolly then commented on the company's recent revenues and growth. "I think we're just scratching the surface," said Calvert. "We have put a couple of really key relationships together. We have new technologies coming into our portfolio. We are incredibly active and dynamic in developing commercial and revenue opportunities of significance."

"Could you give us an update on the company's PFAS project?" asked Jolly. "It's a very exciting opportunity," said Calvert. "There is a mandate by the Biden Administration to get this cleaned up. The beauty of this situation is that we got a little bit of a head start before it crescendoed in the market, which means we have the talent and the technical solution advanced sufficiently to be in commercial mode now."

"We would like to be in the field within the next 60-120 days. [PFAS] is a contaminant that has to come out; it is the environmental disaster of the decade," he explained. "We just think this is such an enormous opportunity. We're going to take it from start to finish and prove that it is a commercially viable, economic, and environmentally-friendly solution. Then we're going to partner with companies and take it all over the world."

Calvert then elaborated on the potential customers for this industry, which will likely include the military, municipal, and industrial clients. "Who serves those people? There are really two classes: environmental engineering firms and specialty large companies dedicated to water," explained Calvert. "Both of those are really distributor and partner opportunities for us."

"What is the outlook for your company over the next twelve months?" asked Jolly. "The hardest work is done," said Calvert. "We have never been more excited than today... we have some financing that really provides the resources to get us through this commercial gap," he continued. "I think this is a time where investor enthusiasm is at an all-time high and it will continue. So, we're a company to watch."

"You need to watch carefully, because the evolution of this company is so dynamic that if you're not looking every six months you will only know about half the story," said Calvert. "The hard work is done, the prize is in front of us, let's go do the work and get it done."

To hear Dennis Calvert's entire interview, follow the link to the podcast here:

Investors Hangout is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at

About BioLargo, Inc.

BioLargo, Inc. (OTCQB: BLGO) invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over 13 years of extensive R&D, BioLargo holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our peer-reviewed scientific approach allows us to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries. With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BioLargo has proven itself with over 80 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. Several of our technologies are commercially available and are advancing as disrupters in their respective markets. See our website at

Contact Information

Dennis P. Calvert

President and CEO, BioLargo, Inc.


Safe Harbor Act

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding the impact of the COVID-19 pandemic; anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of the COVID-19 pandemic on the Company's business, results of operations, financial condition, and stock price; the effect of regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

About The "Stock Day" Podcast

Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America.


Stock Day Media

(602) 821-1102

To view the source version of this press release, please visit

No comments:

Post a Comment